5-Amino-1MQ 5mg For Bodybuilding CAS:42464-96-0

    What is 5-Amino-1MQ?

    5-Amino-1-methylquinolinium iodide, commonly abbreviated as 5-Amino-1MQ, is a small, synthetically derived quinolinium salt. Its core structure features a quinoline ring system with a methyl group at the 1-position and an amino group at the 5-position, carrying a positive charge (cation). Crucially, it is not a hormone, steroid, or selective androgen receptor modulator (SARM). It exists purely as a research chemical, primarily studied in vitro (cell cultures) and in vivo (animal models, notably rodents). It lacks regulatory approval for human consumption as a drug or supplement by any major agency (FDA, EMA, etc.) and is not naturally occurring in significant quantities within the human body or diet.

    The defining feature of 5-Amino-1MQ is its potent and relatively selective inhibition of Nicotinamide N-methyltransferase (NNMT).

    ●NNMT's Role: NNMT is an enzyme predominantly found in the liver and adipose (fat) tissue. Its primary function is to methylate nicotinamide (a form of Vitamin B3, also a NAD+ precursor) using S-adenosyl methionine (SAMe) as the methyl donor. This reaction produces 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH).

    ●The Metabolic Consequence: High NNMT activity is associated with metabolic dysregulation, particularly obesity and insulin resistance. By methylating nicotinamide, NNMT effectively:

    ○Depletes Cellular NAD+: Nicotinamide is a direct precursor for NAD+ biosynthesis via the salvage pathway. Diverting it into 1-MNA reduces the substrate available for NAD+ production.

    ○Consumes Methyl Donors: SAMe, the universal methyl donor, is consumed. This can potentially impact other crucial methylation reactions throughout the body.

    ○Generates SAH: SAH is a potent inhibitor of most other methyltransferases, potentially creating a broader methylation imbalance.

    ●5-Amino-1MQ's Intervention: By inhibiting NNMT, 5-Amino-1MQ aims to:

    ○Increase NAD+ Availability: Less nicotinamide is methylated and wasted, allowing more to be recycled back into NAD+ via the salvage pathway (primarily via the enzyme NAMPT). Elevated NAD+ levels are crucial for mitochondrial function, energy production (ATP), DNA repair (via PARPs), and sirtuin activation.

    ○Conserve Methyl Donors: Less SAMe is consumed by NNMT, potentially freeing it up for other essential methylation processes (e.g., neurotransmitter synthesis, DNA methylation).

    ○Reduce SAH Buildup: Lower NNMT activity means less SAH production, potentially alleviating inhibition on other methyltransferases.

    ●Downstream Effects: The hypothesized cascade for bodybuilding relevance is:
    NNMT Inhibition --> Increased NAD+ --> Enhanced Sirtuin Activity (esp. SIRT1) --> Increased Mitochondrial Biogenesis & Function --> Boosted Fatty Acid Oxidation --> Increased Energy Expenditure & Fat Loss.
    Additionally, improved metabolic efficiency and reduced inflammation (a known consequence of NNMT overexpression) could theoretically create a more anabolic environment conducive to muscle preservation or growth.

    Based solely on its mechanism and preclinical findings, 5-Amino-1MQ is theorized to be applicable in bodybuilding for:

    ●Accelerated Fat Loss: This is the primary proposed benefit. By enhancing mitochondrial fat-burning capacity and increasing overall energy expenditure via elevated NAD+/SIRT1, it could promote lipolysis (fat breakdown) and fatty acid oxidation, particularly during calorie restriction.

    ●Muscle Preservation During Cutting: Maintaining lean muscle mass while in a calorie deficit is paramount for bodybuilders. Increased NAD+/SIRT1 activity may help suppress muscle protein breakdown pathways and improve metabolic efficiency, potentially sparing muscle tissue during aggressive cuts.

    ●Improved Metabolic Health & Insulin Sensitivity: By counteracting the metabolic dysfunction associated with high NNMT (common in obesity), it could improve glucose uptake and insulin sensitivity, leading to better nutrient partitioning – potentially directing more energy towards muscle and away from fat storage.

    ●Enhanced Energy Levels & Endurance: Elevated NAD+ and improved mitochondrial function could translate to better cellular energy production (ATP), reducing fatigue and potentially improving workout performance and recovery.

    ●Anti-Inflammatory Effects: Chronic inflammation hinders recovery and muscle growth. Reduced NNMT activity and increased NAD+/SIRT1 may dampen inflammatory pathways.

    ●Significant Reduction in Adiposity: Rodent studies consistently show potent fat loss effects, even without changes in food intake or physical activity.

    ●Improved Glucose Tolerance and Insulin Sensitivity: Demonstrated in mouse models of diet-induced obesity and diabetes.

    ●Increased Energy Expenditure: Linked to enhanced thermogenesis and mitochondrial uncoupling.

    ●Reduced Hepatic Steatosis (Fatty Liver): Observed in animal models.

    ●Muscle-Sparing Effects (Indirect Evidence): While direct muscle hypertrophy isn't the primary reported effect, the preservation of lean mass during fat loss in studies and the role of NAD+/SIRT1 in muscle metabolism suggest potential.

    ●Potential Anti-Aging Effects: Via NAD+ elevation and sirtuin activation (longevity pathways), though bodybuilding relevance is secondary.

    Crucial Caveat: All human dosing and cycling information is EXTREMELY speculative and derived from extrapolating rodent data. There are NO established safe or effective human protocols. Use is entirely experimental and at personal risk.

    ●Dosage (Based on Rodent Extrapolation & Anecdote):

    ○Rodent studies typically use doses in the range of 5-50 mg per kg of body weight per day. Directly converting this to humans using body surface area normalization (a more accurate method than simple weight conversion) suggests a potential human equivalent dose (HED) roughly in the range of 0.5 mg to 5 mg per kg of body weight per day.

    ○Anecdotal reports from early adopters in the bodybuilding community often fall within 100mg to 300mg total per day, frequently split into two doses (e.g., 100mg AM, 100mg PM). This aligns roughly with the lower end of the HED for a ~70-90kg individual. Starting at the lower end (e.g., 100mg/day) is strongly advised.

    ●Cycle Length:

    ○Preclinical studies often run for several weeks (e.g., 4-12 weeks). Anecdotal cycles mirror this, typically ranging from 4 to 8 weeks. Longer cycles lack any safety data. Due to the unknown long-term effects, shorter cycles (4-6 weeks) with breaks are prudent.

    ●Half-Life:

    ○This is a major unknown. There is no published pharmacokinetic data (absorption, distribution, metabolism, excretion - ADME) for 5-Amino-1MQ in humans, and limited data even in animals. Its molecular structure suggests it might have moderate water solubility due to the charged quaternary nitrogen but also some lipophilic character from the quinoline ring. Anecdotal reports and its mechanism suggest effects may be sustained, leading users to dose once or twice daily. Until proper studies are done, assuming a half-life requiring at least once-daily dosing is reasonable. Twice-daily dosing (e.g., every 12 hours) is common practice based on the desire for stable levels.

    ●Post-Cycle Therapy (PCT):

    ○PCT is generally NOT considered necessary for 5-Amino-1MQ. Unlike anabolic steroids or SARMs, it does not act on the hypothalamic-pituitary-gonadal (HPG) axis. It does not suppress natural testosterone production, aromatize into estrogen, or exhibit significant androgenic or progestogenic activity based on its known mechanism. Therefore, traditional SERM (e.g., Tamoxifen, Clomid) or HCG-based PCT protocols are irrelevant and unnecessary.

    ○The primary "recovery" consideration would be monitoring metabolic parameters and overall well-being after cessation, as the long-term consequences of NNMT inhibition in humans are unknown. A focus on maintaining a healthy diet, training regimen, and potentially supporting NAD+ levels naturally (e.g., NR, NMN) post-cycle might be considered by some, but is not established PCT.

    ●Lack of Human Data: This cannot be overstated. Zero robust clinical trials exist. All purported benefits for bodybuilding are extrapolations from mice and rats. Human physiology differs significantly.

    ●Unknown Safety Profile: Potential side effects in humans are largely unknown. Possible concerns based on mechanism or anecdote include:

    ○Methylation Imbalance: While conserving SAMe is theorized as a benefit, altering NNMT significantly could unpredictably affect the intricate balance of methylation pathways, potentially impacting neurotransmitter synthesis, DNA methylation (gene expression), histamine metabolism, and more. Symptoms could be wide-ranging and subtle.

    ○Gastrointestinal Distress: Nausea, stomach upset, or diarrhea are commonly reported anecdotally, especially at higher doses or initiation.

    ○Headaches/Fatigue: Some users report initial headaches or tiredness.

    ○Long-Term Organ Toxicity: No data exists on effects on liver, kidneys, heart, or brain with chronic use.

    ○Potential Impact on One-Carbon Metabolism: The interplay between NNMT inhibition, SAMe, SAH, homocysteine, folate, and B12 cycles is complex and poorly understood in this context.

    ●Purity and Sourcing: As a research chemical, it is sold by unregulated suppliers. Purity, contaminants (solvents, heavy metals), and accurate dosing are significant concerns. There is no quality control.

    ●Cost: It is often expensive relative to its unproven benefits in humans.

    ●Legal Status: It exists in a grey area, not approved for human consumption but often sold as a "research chemical not for human use." Regulations vary by country.

    ●Interactions: Potential interactions with medications or other supplements are completely unknown.

Trade names	5-amino-1-methylquinolinium,SCHEMBL6403148,CHEMBL4116828, ZMJBCEIHNOWCMC-UHFFFAOYSA-O,STL196667
CAS	42464-96-0
Molar mass	159.21
Formula	C10H11N2
Purity	Above 98%
Apprarance	5mg/vial, 10vials/box

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    5-Amino-1MQ presents a fascinating and novel mechanism for potentially enhancing fat loss and metabolic efficiency by inhibiting NNMT and boosting NAD+ levels. Preclinical data in rodents is compelling, showing significant reductions in fat mass and improvements in metabolic parameters. For bodybuilders, the theoretical applications – accelerated cutting, muscle preservation, improved insulin sensitivity, and enhanced energy – are highly attractive.

    However, the leap from rodents to humans is vast. The complete absence of human safety and efficacy data is the paramount concern. Dosing, cycling, and understanding side effects are based on extrapolation and anecdote, not science. The potential for disrupting critical methylation pathways carries inherent, unknown risks. The sourcing and purity issues add another layer of danger.

    Therefore, while 5-Amino-1MQ represents an intriguing frontier in metabolic manipulation for physique enhancement, it must be approached with extreme caution, skepticism, and a full understanding that its use is highly experimental. It is not a substitute for proven fundamentals: meticulous diet, progressive resistance training, adequate sleep, and stress management. Anyone considering it must weigh the potential, yet unproven, benefits against the significant unknowns and potential risks, ideally under the guidance of a physician knowledgeable in both performance enhancement and metabolic biochemistry (though such guidance will be inherently limited by the lack of data). Currently, it remains firmly in the realm of experimental research, not established bodybuilding practice.

Hot Tags: 5-amino-1mq 5mg for bodybuilding cas:42464-96-0, China 5-amino-1mq 5mg for bodybuilding cas:42464-96-0 manufacturers, suppliers, factory